P2.10. Mechanisms of Acquired Resistance to ALK Inhibitors Using Plasma Sequencing - Preliminary Data from the ATORG004 Study - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Aaron Tan
Meta Tag
Speaker Aaron Tan
Topic Metastatic NSCLC: Targeted Therapy - FUSIONS
acquired resistance
ALK inhibitors
ALK rearranged NSCLC
ATORG004 study
circulating tumor DNA
next-generation sequencing
ALK resistance mutations
MET amplification
DNA damage repair gene alterations
Powered By